Universal Vision Biotechnology Co Ltd
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Furt… Read more
Universal Vision Biotechnology Co Ltd - Asset Resilience Ratio
Universal Vision Biotechnology Co Ltd (3218) has an Asset Resilience Ratio of 21.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2007–2024)
This chart shows how Universal Vision Biotechnology Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Universal Vision Biotechnology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$1.30 Billion | 21.94% |
| Total Liquid Assets | NT$1.30 Billion | 21.94% |
Asset Resilience Insights
- Good Liquidity Position: Universal Vision Biotechnology Co Ltd maintains a healthy 21.94% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Universal Vision Biotechnology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Universal Vision Biotechnology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516 |
Medical Care Facilities | 0.14% |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044 |
Medical Care Facilities | 0.04% |
|
Hengkang Medical Group Co Ltd
SHE:002219 |
Medical Care Facilities | 0.10% |
|
TMC Life Sciences Bhd
KLSE:0101 |
Medical Care Facilities | 11.68% |
|
Optimax Holdings Sdn Bhd
KLSE:0222 |
Medical Care Facilities | 13.92% |
|
Cengild Medical Berhad
KLSE:0243 |
Medical Care Facilities | 27.79% |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283 |
Medical Care Facilities | 19.20% |
|
ALPHA
KLSE:0303 |
Medical Care Facilities | 40.66% |
Annual Asset Resilience Ratio for Universal Vision Biotechnology Co Ltd (2007–2024)
The table below shows the annual Asset Resilience Ratio data for Universal Vision Biotechnology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 24.48% | NT$1.41 Billion | NT$5.76 Billion | +13.21pp |
| 2023-12-31 | 11.27% | NT$578.36 Million | NT$5.13 Billion | -1.52pp |
| 2022-12-31 | 12.80% | NT$576.62 Million | NT$4.51 Billion | -0.69pp |
| 2021-12-31 | 13.49% | NT$505.81 Million | NT$3.75 Billion | -1.08pp |
| 2020-12-31 | 14.57% | NT$461.75 Million | NT$3.17 Billion | +1.77pp |
| 2019-12-31 | 12.80% | NT$338.97 Million | NT$2.65 Billion | -4.29pp |
| 2018-12-31 | 17.09% | NT$358.41 Million | NT$2.10 Billion | +7.87pp |
| 2017-12-31 | 9.22% | NT$184.89 Million | NT$2.00 Billion | -4.85pp |
| 2016-12-31 | 14.07% | NT$245.21 Million | NT$1.74 Billion | +8.04pp |
| 2015-12-31 | 6.03% | NT$113.99 Million | NT$1.89 Billion | -17.19pp |
| 2014-12-31 | 23.22% | NT$418.63 Million | NT$1.80 Billion | -1.52pp |
| 2013-12-31 | 24.75% | NT$337.88 Million | NT$1.37 Billion | +24.03pp |
| 2012-12-31 | 0.72% | NT$9.03 Million | NT$1.26 Billion | -1.31pp |
| 2011-12-31 | 2.03% | NT$28.10 Million | NT$1.38 Billion | +1.06pp |
| 2009-12-31 | 0.98% | NT$10.91 Million | NT$1.12 Billion | -0.04pp |
| 2008-12-31 | 1.01% | NT$11.03 Million | NT$1.09 Billion | -13.41pp |
| 2007-12-31 | 14.42% | NT$101.63 Million | NT$704.59 Million | -- |